Hostname: page-component-77c89778f8-n9wrp Total loading time: 0 Render date: 2024-07-18T20:27:42.912Z Has data issue: false hasContentIssue false

In Vivo X-Ray Fluorescence of Lead and Other Toxic Trace Elements

Published online by Cambridge University Press:  06 March 2019

David R. Chettle*
Affiliation:
Department of Physics and Astronomy, McMaster University Hamilton, Ontario, Canada
Get access

Abstract

The first in vivo x-ray fluorescence measurements of lead in bone used y-rays from a 57Co source to excite Pb K x-rays. Later systems used γ-rays from 109Cd to excite Pb K x-rays or polarized x-rays to excite Pb L x-rays. All three approaches involve an extremely low effective dose to the subject. Of the two K x-ray techniques, 109Cd is more precise and more flexible in choice of measurement site. Pb L x-ray fluorescence (L-XRF) effectively samples lead at bone surfaces, whereas Pb K x-ray fluorescence (K-XRF) samples through the bulk of a bone. Both the polarized L-XRF and 109Cd K-XRF achieve similar precision.

Renal mercury has recently been determined using a polarized x-ray source. Both renal and hepatic cadmium can be measured using polarized x-rays in conjunction with a Si(Li) detector. Platinum and gold have been measured both by radioisotopic source excitation and by using polarized x-rays, but the latter is to be preferred.

Applications of Pb K-XRF have shown that measured bone lead relates strongly to cumulative lead exposure. Secondly, biological half lives of lead in different bone types have been estimated from limited longitudinal data sets and from some cross sectional surveys. Thirdly, the effect of hone lead as an endogenous source of lead has been demonstrated and it has been shown that a majority of circulating blood lead can be mobilized from bone, rather than deriving from new exposure, in some retired lead workers.

Type
VIII. In Vivo Applications of XRS
Copyright
Copyright © International Centre for Diffraction Data 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ahlgren, L., Liden, K., Mattsson, S., Tejning, S., “X-ray fluorescence analysis of lead in human skeleton in vivo” Scandinavian Journal of Work, Environment and Health 2, 8286, 1976.Google Scholar
Ahlgren, L., Mattsson, S., “Cadmium in man measured in vivo by X-ray fluorescence” Physics in Medicine and Biology 26, 1926, 1981.Google Scholar
Armstrong, R., Chettle, D.R., Scott, M.C., Somervaille, L.J., Pendlington, M., “Repeated measurements of tibia lead by in vivo X-ray fluorescence in occupational exposure” British Journal of Industrial Medicine 49, 1416, 1992.Google Scholar
Belkin, M., Chajek, T., Zeimer, R., Friedman, G., Melamed, E., “Non-invasive quantitation of corneal copper in hepatolenticular degeneration (Wilson's Disease).” The Lancet, 1, 391392, 1976.Google Scholar
Bloch, P., Garavaglia, G., Mitchell, G., Shapiro, I.M., “Measurement of lead content of children's teeth in situ by X-ray fluorescence” Physics in Medicine and Biology 22, 5663, 1977.Google Scholar
Bloch, P., Shapiro, I.M., “An X-ray fluorescence technique to measure the mercury burden of dentists in vivo:Medical Physics, 8, 308311, 1981.Google Scholar
Borjesson, J., “Measurements of platinum, gold and mercury in vivo.” Fil. Lie. thesis, Radiofysik, Goteborgs Universitet, Sweden, 1991.Google Scholar
Borjesson, J., Alpsten, M., Barregard, L., Johnson, R., Mattsson, S., Schatz, A., Sallsten, G., “Bestamning av kvicksilver in vivo hos yrkesbetingat expoerade”, presented at the annual meeting of the Swedish Society of Medicine, Stockholm, December, 1993a.Google Scholar
Borjesson, J., Gerhardsson, L., Mattsson, S., Msson, A., Schutz, A., Skerfving, S., Stromberg, U., “In vivo matning av bly i ben hos langtidsesponerade blyarbetare”, presented at the annual meeting of the Swedish Society of Medicine, Stockholm, December, 1993b.Google Scholar
Cake, K.M., Chettle, D.R., Webber, C.E., Gordon, C.L., Bowins, R.J., McNutt, R.H., Vaillancourt, C., “In vivo X-ray fluorescence of bone lead in the study of human lead metabolism: serum lead, whole blood lead, bone, lead and cumulative exposure.” Applications of X-ray Analysis, 43rd annual Denver X-ray Conference.Google Scholar
Christoffersson, J-O., Mattsson, S., “Polarised X-rays in XRF-analysis for improved in vivo detectability of cadmium” Physics in Medicine and Biology 28, 11351144, 1983.Google Scholar
Christoffersson, J-O., Schutz, A., Ahlgren, L., Haeger-Aronsen, B., Mattsson, S., Skerfving, S., “Lead in finger bone analysed in vivo in active and retired lead workers” American Journal of Industrial Medicine 6, 447457, 1984.Google Scholar
Erkkila, J., Armstrong, R., Riihimaki, V., Chettle, D.R., A Paakkari, Scott, M., Somervaille, L., Starck, J., Kock, B., Aitio, A., In vivo measurements of lead in bone at four anatomical sites: long term occupational and consequent endogenous exposure.”, British Journal of Industrial Medicine 49, 631644, 1992.Google Scholar
Franklin, D.M., Armstrong, R., Chettle, D.R., M.C Scott, “An Improved Neutron Activation System for Measuring Kidney Cadmium”, Physics in Medicine and Biology 35, 13971408, 1990.Google Scholar
Gerhardsson, L., Attewell, R., Chettle, D.R., Englyst, V., N-Lundstrom, G., Nordberg, G.F., Nyhlin, H., Scott, M.C., Todd, A.C., “ In vivo measurements of lead in bone in long-term exposed lead smelter workers”, Archives of Environmental Health, 48, 147156 1993.Google Scholar
Gordon, C.L., Chettle, D.R., Webber, C.E., “An improved instrument for the in vivo detection of bone lead”, British Journal of Industrial Medicine, 50, 637641, 1993.Google Scholar
Grdnberg, T., Almen, T., Gorman, K., Liden, K., Mattsson, S., Sjoberg, S., “Nan invasive estimation of kidney function by X-ray fluorescence analysis: Method for in vivo measurements of iodine containing contrast media in rabbits.” Physics in Medicine and Biology, 26, 501506, 1981.Google Scholar
Hoffer, P.B., Jones, W.B., Crawford, R.B., Beck, R., Gottschalk, A., “Fluorescent thyroid scanning: A new method of imaging the thyroid.” Radiology, 90, 342344, 1968.Google Scholar
Hu, H., Pepper, L., Goldman, R., “Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone” American Journal of Industrial Medicine 20, 723735, 1991.Google Scholar
Jonson, R., Mattsson, S., Unsgaard, B., “A method for in vivo analysis of platinum after chemotherapy with cisplatin.” Physics in Medicine and Biology, 33, 847857, 1988.Google Scholar
Kalef-Ezra, J.A., Slatkin, D.N., Rosen, J.F., Wielopolski, L., “Radiation risk to the human conceptus from measurement of maternal lead by L-lineX-ray fluorescence” Health Physics 58, 217218, 1990.Google Scholar
Leggett, R.W., “An age-specific kinetic model of lead metabolism in humans” Environmental Health Perspectives 101, 598616, 1993.Google Scholar
Nilsson, U., Ahlgren, L., Christoffersson, J-O., Mattsson, S., “Further improvement of XRF analysis of cadmium in vivo” in In Vivo Body Composition Studies” ed. S. Yasumura, J.E.Google Scholar
Harrison K.G., McNeill, Woodhead, A.D., Dilmanian, F.A., Plenum Press, New York, 1990, pp 297301.Google Scholar
Nilsson, U., Attewell, R., Christoffersson, J-O., Schiitz, A., Ahlgren, L., SkerfVing, S., Mattsson, S., “Kinetics of lead in bone and blood after end of occupational exposurePharmacology and Toxicology 69, 477484, 1991.Google Scholar
Price, J., Grudzinski, A.W., Craswell, P.W., BJ, Thomas, “Repeated bone lead levels in Queensland, Australia- Previously a high lead environment” Archives of Environmental Health 47, 256262, 1992.Google Scholar
Shakeshaft, J., Clarke, A.K., Evans, M., Lillicrap, S.C., “X-ray fluorescence determination of gold in vivo.”, in ‘Human Body Composition: In Vivo Methods, Models, and Assessment', ed.Google Scholar
Ellis, K.J., Eastman, J.D., Plenum Press, pp 307-310, 1993.Google Scholar
Snyder, R.E., Secord, D.C., “The in situ measurement of strontium content in bone using x-ray fluorescence analysis.” Physics in Medicine and Biology, 27, 515529, 1982.Google Scholar
SomervaJlle, L.J., Chettle, D.R., Scott, M.C., In vivo measurement of lead in bone using x-ray fluorescence” Physics in Medicine and Biology 30, 929943, 1985.Google Scholar
SomervaJlle, L.J., Chettie, D.R., Scott, M.C., A.C Aufderheide, Wallgren, J.E., Wittmers, L.E. Jr., Rapp, G.R. Jr., “Comparison of two in vitro methods of bone lead analysis and the implications for in vivo measurements” Physics in Medicine and Biology 31, 12671274, 1986.Google Scholar
Somervaille, L.J., Chettle, D.R., Scott, M.C., Tennant, D.R., McKiernan, M.J., Skilbeck, A., Trethowan, W.N., In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects” British Journal of Industrial Medicine 45, 174181, 1988.Google Scholar
Somervaille, L.J., Nilsson, U., Chettle, D.R., Tell, I., Scott, M.C., Schiitz, A., Mattsson, S., S, SkerfVing, In vivo measurements of bone lead - a comparison of two x-ray fluorescence techniques used at three different bone sites” Physics in Medicine and Biology 34, 1833–1545, 1989.Google Scholar
Todd, A.C., McNeill, F.E., Palethorpe, J.E., Peach, D.E., Chettle, D.R., Tobin, M.J. Strosko, S.J., J.C Rosen, In vivo XRF of lead in bone using K X-ray excitation with Cd sources: radiation dosimetry studies”, Environmental Research 57, 117132, 1992.Google Scholar
Todd, A.C., Chettle, D.R., “Jn vivo X-my fluorescence of lead in bone'. Review and current issues” Environmental Health Perspectives 102, 172177, 1994.Google Scholar
Wielopolski, L., Rosen, J.F., Slatkin, D.N., Vartsky, D., Ellis, K.J., Colin, S.H., “Feasibility of noninvasive analysis of lead in the human tibia by soft X-ray fluorescence” Medical Physics 10, 248251, 1983.Google Scholar
Wielopolski, L., Rosen, J.F., Slatkin, D.N., Zhang, R., Kalef-Ezra, J.A., Rothman, J.C., Maryanski, M., Jenks, S.T., In vivo measurement of cortical bne lead using polarized X-rays” Medical Physics 16, 521528, 1989.Google Scholar